Valhi Q2 EPS surges 2500% on Chemicals segment strength
Valhi Inc. delivered strong Q2 2026 results with net income surging 2500% to $22.3 million, driven by robust performance in the Chemicals Segment. Volume growth and cost reductions offset lower TiO2 prices, leading to expanded operating margins.
*this image is generated using AI for illustrative purposes only.
Valhi, Inc. (NYSE: VHI) reported net income attributable to stockholders of $22.3 million, or $.78 per share, for the second quarter of 2026, marking a 2500 percent year-over-year increase from $.9 million, or $.03 per share, in the same period of 2025. The company’s total net sales reached $606.1 million, up 12 percent from $540.4 million in the prior-year quarter. This significant expansion in profitability was primarily driven by higher operating results from the Chemicals Segment, which benefited from market share gains and lower production costs despite headwinds from lower titanium dioxide (TiO2) selling prices.
Financial Performance
The company’s results reflect strong operational leverage across its business units. For the first six months of 2026, Valhi reported net income of $24.3 million, or $.85 per share, compared to $17.8 million, or $.62 per share, in the first half of 2025. Total operating income for the quarter rose to $67.7 million from $35.5 million in the prior-year period.
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Net Sales | $606.1 million | $540.4 million | 12% |
| Net Income (Stockholders) | $22.3 million | $.9 million | 2500% |
| Earnings Per Share | $.78 | $.03 | 2500% |
| Operating Income | $67.7 million | $35.5 million | 91% |
Segment Highlights
The Chemicals Segment delivered the most substantial growth, with net sales rising 13 percent to $558.1 million. This increase was fueled by a 16 percent rise in TiO2 sales volumes and favorable currency exchange impacts, which added approximately $10 million to sales. These gains were partially offset by a 3 percent decline in TiO2 product pricing. Operating income for the segment surged to $40.4 million from $10.3 million, driven by higher volumes, lower raw material costs, and benefits from cost reduction initiatives implemented in late 2025.
The Component Products Segment saw net sales increase to $43.6 million from $40.3 million, supported by higher security products sales across healthcare and transportation markets. Operating income rose to $8.9 million from $6.3 million. Conversely, the Real Estate Management and Development Segment experienced a decline in net sales to $4.4 million from $5.7 million due to slower development activity as projects near completion. However, the segment recognized a $5.8 million gain on the sale of an office building during the quarter.
What the Numbers Show
The divergence between revenue growth and earnings growth highlights Valhi’s improved cost structure. While total sales grew by 12 percent, operating income nearly doubled, indicating that fixed cost absorption and lower variable costs significantly boosted margins. The Chemicals Segment’s ability to grow volumes by 16 percent despite lower average selling prices suggests strong market demand and competitive positioning. Additionally, the company benefited from tax increment infrastructure reimbursements of $16.7 million in the first half of 2026, providing a non-operational boost to net income. Corporate expenses decreased by 2 percent in the quarter, primarily due to lower environmental remediation costs, further supporting the bottom line.
Can Valhi sustain its 16% volume growth in TiO2 sales if industry-wide pricing pressures continue to intensify?
How will the depletion of the $16.7 million tax increment infrastructure reimbursements impact Valhi's net income trajectory in subsequent quarters?
What specific strategic initiatives is Valhi pursuing to offset the declining revenue trend in its Real Estate Management and Development segment as projects near completion?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
